Metabolomic investigation of cisplatin-induced acute kidney injury in paediatric cancer patients.

Saved in:
Bibliographic Details
Title: Metabolomic investigation of cisplatin-induced acute kidney injury in paediatric cancer patients.
Authors: Lim YJ; Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada., Thachil A; Division of Nephrology, Department of Pediatrics, British Columbia Children's Hospital, Vancouver, British Columbia, Canada., McMahon K; Department of Pediatrics, Division of Nephrology, Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada., Tsuyuki RT; Epicore Center, Department of Medicine, Department of Pharmacology, University of Alberta, Edmonton, Alberta, Canada., Rassekh SR; Division of Oncology, Hematology and Bone Marrow Transplant, Department of Pediatrics, Faculty of Medicine, BC Children's Hospital and University of British Columbia, Vancouver, Canada., Mitchell LG; Department of Pediatrics, University of Alberta, Edmonton, Alberta, Canada., Devarajan P; Division of Nephrology and Hypertension, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA., Mammen C; Division of Nephrology, Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada., Carleton BC; Department of Medical Genetics, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada., Cuvelier GDE; Alberta Children's Hospital, University of Calgary, Calgary, Alberta, Canada., Lewis VA; Pediatric Oncology and Transplant, Alberta Children's Hospital, University of Calgary, Calgary, Alberta, Canada., Ross CJD; Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada., Zorzi AP; Division of Pediatric Hematology-Oncology, Children's Hospital London Health Sciences Centre, London, Ontario, Canada., Baruchel S; Translational Medicine, The Hospital for Sick Children Research Institute, University of Toronto, Toronto, Ontario, Canada., Ramphal R; Division of Hematology and Oncology, Department of Pediatrics, Children's Hospital of Eastern Ontario-Ottawa Children's Treatment Centre, Ottawa, Ontario, Canada., Bouffet E; Division of Nephrology, Department of Pediatrics, Hospital for Sick Children, Toronto, Ontario, Canada., Lemaire M; Division of Nephrology, Department of Pediatrics, Hospital for Sick Children, Toronto, Ontario, Canada., Blydt-Hansen TD; Division of Nephrology, Department of Pediatrics, British Columbia Children's Hospital, Vancouver, British Columbia, Canada., Urquhart BL; Department of Physiology and Pharmacology, Schulich School of Medicine & Dentistry, Western University, London, Ontario, Canada.; Division of Nephrology, Department of Medicine, Schulich School of Medicine & Dentistry, Western University, London, Ontario, Canada.
Corporate Authors: Applying Biomarkers to Minimize Long‐Term Effects of Childhood/Adolescent Cancer Treatment (ABLE) Research Study Group
Source: British journal of clinical pharmacology [Br J Clin Pharmacol] 2026 May 06, pp. e70587. Date of Electronic Publication: 2026 May 06.
Publication Type: Journal Article
Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7503323 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2125 (Electronic) Linking ISSN: 03065251 NLM ISO Abbreviation: Br J Clin Pharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1365-2125
DOI:10.1002/bcp.70587